Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

7.49

Change

+0.03 +0.40%

Volume

Volume 59,988

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 7.76

$ 7.46

Change

-0.30 -3.87%

Day low

Day high

$7.28

$7.80

Open

52 week low

52 week high

$2.43

$46.25

Open

Edward Wood Pastorius

Edward Wood Pastorius is Chief Revenue Officer for Tilray, Inc. and President-North America at Tilray Canada Ltd.

In his past career he occupied the position of Chief Executive Officer of HEALTHeCAREERS Network, President & Chief Executive Officer at MyWedding LLC, President & Chief Operating Officer at Infotrieve, Inc., Chief Information Officer & EVP-Operations at Thomson Corp., Chief Information Officer at OnTargetJobs, Inc. and General Manager-First Data Screening Services at First Data Corp.

He received an undergraduate degree from Colorado State University and an MBA from New York Institute of Technology.

Transactions

Date Shares Transaction Value
07/05/2020 7,822   Derivative/Non-derivative trans. at $3.13 per share. 24,482
07/05/2020 4,693   Derivative/Non-derivative trans. at $5.28 per share. 24,779
07/01/2020 1,812   Derivative/Non-derivative trans. at $7.01 per share. 12,703
07/01/2020 6,250   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2020 6,250   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2020 2,135   Derivative/Non-derivative trans. at $17.13 per share. 36,573
01/01/2020 6,250   Derivative/Non-derivative trans. at $0 per share. 0
12/12/2019 41,015   Award at $0 per share. 0
12/12/2019 49,985   Award at $0 per share. 0
12/12/2019 61,729   Award at $0 per share. 0
10/01/2019 2,749   Derivative/Non-derivative trans. at $24.18 per share. 66,471
10/01/2019 6,250   Derivative/Non-derivative trans. at $0 per share. 0
07/01/2019 1,761   Derivative/Non-derivative trans. at $49.3 per share. 86,818
07/01/2019 6,250   Derivative/Non-derivative trans. at $0 per share. 0
04/05/2019 3,443   Disposition at $61.04 per share. 210,161
04/02/2019 2,807   Disposition at $63.78 per share. 179,031
04/01/2019 6,250   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2019 3,062   Disposition at $64.8 per share. 198,418
04/01/2019 6,600   Disposition at $64.14 per share. 423,324
04/01/2019 34,088   Disposition at $63.08 per share. 2,150,272
04/01/2019 43,750   Derivative/Non-derivative trans. at $7.76 per share. 339,500
01/28/2019 29,422   Disposition at $72.57 per share. 2,135,155
01/24/2019 20,578   Disposition at $74.21 per share. 1,527,094
01/23/2019 50,000   Derivative/Non-derivative trans. at $0 per share. 0
07/23/2018 14,705   Acquisition at $17 per share. 249,985

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Mr. Mark Castaneda
Head-Strategic Business Development
Mr. Edward Wood Pastorius
Chief Revenue Officer
Mr. Andrew Pucher
Chief Corporate Development Officer
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.